Inactive Instrument

Accretive Health, Inc. Stock price Nyse

Equities

US00438V1035

Healthcare Facilities & Services

End-of-day quote Nyse
- USD 0.00% Intraday chart for Accretive Health, Inc.
Sales 2024 * 2.64B Sales 2025 * 2.95B Capitalization 5.41B
Net income 2024 * -3M Net income 2025 * 130M EV / Sales 2024 * 2.75 x
Net Debt 2024 * 1.84B Net Debt 2025 * 1.62B EV / Sales 2025 * 2.38 x
P/E ratio 2024 *
-763 x
P/E ratio 2025 *
58.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 34.91%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer - 22-06-21
Director of Finance/CFO - 22-06-20
President 48 03-12-31
Members of the board TitleAgeSince
Director/Board Member 74 19-08-11
Director/Board Member 55 21-04-17
Director/Board Member 52 13-03-31
More insiders
R1 RCM Inc. is a provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups. The Company’s scalable operating models seamlessly complement a healthcare organization’s infrastructure, driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. The Company delivers solutions to customers through technology, intellectual property (IP), global scale, and operational excellence. Its Intelligent Automation modernizes processes, removes friction, and simplifies revenue cycle management (RCM). Its use of artificial intelligence (AI) in its platform depends on the availability and pricing of equipment and technical infrastructure from third parties, including Microsoft Azure. It serves over 3,700 hospitals, including 93 of the top 100 health systems, and over 30,000 physicians.
More about the company
  1. Stock
  2. Equities
  3. Stock R1 RCM Inc.
  4. Stock Accretive Health, Inc. - Nyse